Nora Mineva


Nora Mineva 
BA, MA, Biology
Clark University
Worcester, MA
PhD, Pathology 
Boston University 
Boston, MA
Research Associate
Gail Sonenshein, PhD, Adviser


Inflammatory breast cancer is a rare but highly aggressive form of breast cancer. It is characterized by rapid onset and clinical features which are often misdiagnosed as acute mastitis or breast abscess, leading to a delay in proper treatment. Surgery, radiation and chemotherapy have significantly improved patient survival but still, in most cases, the outcome remains poor. My work in the lab focuses on defining the signaling pathways characteristic to inflammatory breast cancer and examining the potential use of Epigallocatechin-3-Gallate (EGCG), a green tea polyphenol with anti-oxidant and anti-cancer qualities, in the treatment of this aggressive disease.

Back to the G Sonenshein Profile Page

Apply to the Sackler School


The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development